Journal List > Allergy Asthma Respir Dis > v.3(2) > 1059090

Park, Kim, Kim, Shin, Park, Kwon, Moon, Cho, and Kim: Heart transplantation in a patient with eosinophilic granulomatosis with polyangiitis known as Churg-Strauss syndrome

Abstract

Eosinophilic granulomatosis with polyangiitis (EGPA), also known as Churg-Strauss syndrome, is a rare systemic necrotizing vasculitis affecting small- to medium-sized vessels. EGPA is associated with severe asthma and eosinophilia. The most frequently involved organs are skin and peripheral nerves; however, EGPA may involve other organs, such as the gastrointestinal tract, kidney, and heart. Antineutrophil cytoplasm antibodies (ANCAs)-related abnormal immune reactions are known to be associated with EGPA, but only 30%-40% of patients have a positive marker of ANCA. ANCA-negative patients are at higher risk of cardiac involvement than ANCA-positive patients. Cardiac involvement is one of the leading causes of mortality and could be resistant to conventional treatment. Early treatment with steroid plus cyclophosphamide is important because it could give chances of restoration of cardiac function. For patients undergoing heart transplantation, we should consider the severity of cardiac disease and the presence of systemic diseases, including vasculitis. Here, we report a case of a 25-year-old EGPA patient with cardiac involvement who eventually received heart transplantation for progressive heart failure, although treated with systemic corticosteroid with cyclophosphamide. EGPA patients undergoing heart transplantion are rarely reported worldwide, and this is the first case report in Korea.

Figures and Tables

Fig. 1

Initial electrocardiogram shows atrial fibrillation with rapid ventricular response and right bundle branch block.

aard-3-159-g001
Fig. 2

(A) Initial chest x-ray: Image shows cardiomegaly, increased pulmonary vascularity and small amount of pleural effusion. (B) Posttransplantation chest x-ray: Cardiomegaly is markedly improved.

aard-3-159-g002
Fig. 3

(A) Preoperative echocardiography shows severely dilated left ventricle, global hypokinesia with atrial fibrillation. (B) Postoperative echocardiography shows normal findings with ejection fraction of 57%.

aard-3-159-g003
Fig. 4

Trends of blood eosinophil levels and brain natriuretic peptide (BNP). EF, ejection fraction; QOD, every other day; bid, twice a day.

aard-3-159-g004

References

1. Ramentol-Sintas M, Martinez-Valle F, Solans-Laque R. Churg-Strauss Syndrome: an evolving paradigm. Autoimmun Rev. 2012; 12:235–240.
crossref
2. Mouthon L, Dunogue B, Guillevin L. Diagnosis and classification of eosinophilic granulomatosis with polyangiitis (formerly named Churg-Strauss syndrome). J Autoimmun. 2014; 48-49:99–103.
crossref
3. Vaglio A, Martorana D, Maggiore U, Grasselli C, Zanetti A, Pesci A, et al. HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome. Arthritis Rheum. 2007; 56:3159–3166.
crossref
4. Sinico RA, Bottero P. Churg-Strauss angiitis. Best Pract Res Clin Rheumatol. 2009; 23:355–366.
crossref
5. Groh M, Masciocco G, Kirchner E, Kristen A, Pellegrini C, Varnous S, et al. Heart transplantation in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome). J Heart Lung Transplant. 2014; 33:842–850.
crossref
6. Vinit J, Bielefeld P, Muller G, Pfitzenmeyer P, Bonniaud P, Lorcerie B, et al. Heart involvement in Churg-Strauss syndrome: retrospective study in French Burgundy population in past 10 years. Eur J Intern Med. 2010; 21:341–346.
crossref
7. Kobayashi D, Wada Y, Takata T, Koya T, Murakami S, Ozawa T, et al. A severe form of Churg-Strauss syndrome complicated with acute cardiac failure and rapidly progressive peripheral neuropathy: a possible effect of intravenous immunoglobulin therapy. Intern Med. 2011; 50:925–929.
crossref
8. Abril A. Churg-strauss syndrome: an update. Curr Rheumatol Rep. 2011; 13:489–495.
crossref
9. Mehra MR, Kobashigawa J, Starling R, Russell S, Uber PA, Parameshwar J, et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006. J Heart Lung Transplant. 2006; 25:1024–1042.
crossref
10. Rosenberg M, Lorenz HM, Gassler N, Katus HA, Frey N. Rapid progressive eosinophilic cardiomyopathy in a patient with Churg-Strauss syndrome (CSS). Clin Res Cardiol. 2006; 95:289–294.
crossref
11. Corradi D, Maestri R, Facchetti F. Postpartum Churg-Strauss syndrome with severe cardiac involvement: description of a case and review of the literature. Clin Rheumatol. 2009; 28:739–743.
crossref
12. Miloslavsky E, Unizony S. The heart in vasculitis. Rheum Dis Clin North Am. 2014; 40:11–26.
crossref
13. Pfeil A, Brehm B, Lopatta E, Neumann T, Schmidt P, Wolf G, et al. Acute chest pain, heart failure, and eosinophilia in a woman without coronary disease. Cardiovasc Intervent Radiol. 2009; 32:1272–1274.
crossref
14. Ribi C, Cohen P, Pagnoux C, Mahr A, Arene JP, Lauque D, et al. Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients. Arthritis Rheum. 2008; 58:586–594.
crossref
15. Samson M, Puechal X, Devilliers H, Ribi C, Cohen P, Stern M, et al. Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) enrolled in two prospective trials. J Autoimmun. 2013; 43:60–69.
crossref
16. Comarmond C, Pagnoux C, Khellaf M, Cordier JF, Hamidou M, Viallard JF, et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum. 2013; 65:270–281.
crossref
17. Castel MA, Farrero M, Vallejos I, Cardona M, Regueiro A, Perez-Villa F. Primary immunosuppression and outcome differences after heart transplantation: tacrolimus versus cyclosporine. Transplant Proc. 2011; 43:2244–2246.
crossref
18. Grimm M, Rinaldi M, Yonan NA, Arpesella G, Arizon Del, Pulpon LA, et al. Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients: a large European trial. Am J Transplant. 2006; 6:1387–1397.
crossref
TOOLS
Similar articles